Show simple item record

dc.contributor.authorMcKinley, Sophia K.
dc.contributor.authorSingh, Preeti
dc.contributor.authorYin, Kanhua
dc.contributor.authorWang, Jin
dc.contributor.authorZhou, Jingan
dc.contributor.authorBao, Yujia
dc.contributor.authorWu, Menghua
dc.contributor.authorPathak, Kush
dc.contributor.authorMullen, John T.
dc.contributor.authorBraun, Danielle
dc.contributor.authorHughes, Kevin S.
dc.date.accessioned2022-02-09T16:03:53Z
dc.date.available2021-09-20T17:41:48Z
dc.date.available2022-02-09T16:03:53Z
dc.date.issued2021-03
dc.date.submitted2020-12
dc.identifier.issn1357-0560
dc.identifier.issn1559-131X
dc.identifier.urihttps://hdl.handle.net/1721.1/132075.2
dc.description.abstractAbstract Pathogenic variants in germline cancer susceptibility genes can increase the risk of a large number of diseases. Our study aims to assess the disease spectrum of gastric cancer susceptibility genes and to develop a comprehensive resource of gene–disease associations for clinicians. Twenty-seven potential germline gastric cancer susceptibility genes were identified from three review articles and from six commonly used genetic information resources. The diseases associated with each gene were evaluated via a semi-structured review of six genetic resources and an additional literature review using a natural language processing (NLP)-based procedure. Out of 27 candidate genes, 13 were identified as gastric cancer susceptibility genes (APC, ATM, BMPR1A, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH-Biallelic, PALB2, SMAD4, and STK11). A total of 145 gene–disease associations (with 45 unique diseases) were found to be associated with these 13 genes. Other gastrointestinal cancers were prominent among identified associations, with 11 of 13 gastric cancer susceptibility genes also associated with colorectal cancer, eight genes associated with pancreatic cancer, and seven genes associated with small intestine cancer. Gastric cancer susceptibility genes are frequently associated with other diseases as well as gastric cancer, with potential implications for how carriers of these genes are screened and managed. Unfortunately, commonly used genetic resources provide heterogeneous information with regard to these genes and their associated diseases, highlighting the importance of developing guides for clinicians that integrate data across available resources and the medical literature.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttps://doi.org/10.1007/s12032-021-01495-wen_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceSpringer USen_US
dc.titleDisease spectrum of gastric cancer susceptibility genesen_US
dc.typeArticleen_US
dc.identifier.citationMedical Oncology. 2021 Mar 24;38(5):46en_US
dc.contributor.departmentMassachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
dc.relation.journalMedical Oncologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2021-03-25T04:40:49Z
dc.language.rfc3066en
dc.rights.holderSpringer Science+Business Media, LLC, part of Springer Nature
dspace.embargo.termsY
dspace.date.submission2021-03-25T04:40:49Z
mit.journal.volume38en_US
mit.journal.issue5en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusAuthority Work Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version